Clinical histories and molecular characterization of two afibrinogenemic patients: insights into clinical management.

Abstract

positive patients of a total of 13 haemophilics at 90 months [9]. Coagulation factor substitution was managed by bolus or continuous infusion and was stopped at a median of 1 day post-transplantation. During follow-up, no bleeding complications were reported in our study. Recurrence of HCV infection is a frequent problem after liver transplantation for hepatitis C cirrhosis. Some patients develop acute hepatitis in the graft during the early postoperative period and most will suffer from chronic liver disease. In this sense, Mc Carthy reported that 100% of their patients (n = 4) had evidence of recurrent viremia [10]. In our experience, 44% of the HCV recipients relapsed. Conclusion

DOI: 10.1111/j.1365-2516.2011.02656.x

1 Figure or Table

Cite this paper

@article{Grandone2012ClinicalHA, title={Clinical histories and molecular characterization of two afibrinogenemic patients: insights into clinical management.}, author={Elvira Grandone and Giovanni L Tiscia and Filomena Cappucci and Giovanni Favuzzi and Rosa Santacroce and Daniela Pisanelli and Fa‘apisa M. Soli and Cristina Legnani and Matthew Rizzo and Gualtiero Palareti and Maurizio Margaglione}, journal={Haemophilia : the official journal of the World Federation of Hemophilia}, year={2012}, volume={18 1}, pages={e16-8} }